SYK inhibitors (Origenis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSYK inhibitors (Origenis)
Drug Alias Namespleen tyrosine kinase inhibitors (Origenis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSpleen tyrosine kinase inhibitors
TargetsSpleen tyrosine kinase
Therapy Area/IndicationsGastrointestinal DiseasesMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrigenis GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrigenis GmbH
Active IndicationsN/A
Inactive IndicationsGastrointestinal DiseasesMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A